\-\ Texto\\:\\ \ \(0\)\
\-\ osteoporosis\\,\\ patchy\\ osteonecrosis\\,\\ subchondral\\ radiolucent\\ lines\\ \\(crescent\\ sign\\)\\,\\ osseous\\ collapse\\,\\ and\\ fragmentation\\ are\\ recognized\\.\ \(0\)\
\-\ osteonecrosis\\ of\\ both\\ humeral\\ heads\ \(0\)\
\-\ causes\\:\ \(5\)\
\-\ \\	pancreatitis\\,\\ pregnancy\ \(0\)\
\-\ \\	lupus\\ erythematosus\ \(0\)\
\-\ \\	alcoholism\\,\\ atherosclerosis\ \(0\)\
\-\ \\	steroids\ \(0\)\
\-\ \\	trauma\\ \ \(0\)\
\-\ \\	idiopathic\\,\\ infection\ \(0\)\
\-\ \\	caisson\\ disease\\,\\ collagen\\ diseases\\,\\ cancer\ \(0\)\
\-\ \\	rheumatoid\\ arthritis\\,\\ radiation\\ tx\ \(0\)\
\-\ \\	amyloid\ \(0\)\
\-\ \\	gaucher\\ disease\ \(0\)\
\-\ \\	sickle\\ cell\\ dz\ \(0\)\
\-\ \\(mnemonic\\ \\-\\ p\\ l\\ a\\ s\\ t\\ i\\ c\\ \\ \\ r\\ a\\ g\\ s\\)\ \(0\)\
\-\ 43\\ yo\\ male\\ with\\ a\\ h\\/o\\ crohn\\â\\€\\™s\\ disease\\ and\\ long\\ term\\ steroid\\ use\\.\ \(0\)\
\-\ this\\ is\\ a\\ good\\ case\\ of\\ steroid\\ induced\\ bilateral\\ humeral\\ head\\ osteonecrosis\\.\\ \\ this\\ particular\\ patient\\ had\\ a\\ history\\ of\\ crohn\\â\\€\\™s\\ disease\\ and\\ long\\ term\\ steroid\\ use\\ for\\ the\\ past\\ several\\ years\\,\\ placing\\ him\\ at\\ a\\ significantly\\ higher\\ risk\\ for\\ avn\\.\\ \\ \ \(0\)\
\-\ with\\ the\\ multifocal\\ involvement\\,\\ steroid\\ induced\\ avn\\ becomes\\ the\\ leading\\ diagnosis\\ \\(95\\%\\)\\.\\ \\ furthermore\\,\\ he\\ has\\ no\\ history\\ of\\ any\\ other\\ diseases\\,\\ trauma\\,\\ or\\ significant\\ life\\-style\\ practices\\ that\\ place\\ him\\ at\\ risk\\ for\\ osteonecrosis\\,\\ making\\ the\\ steroids\\ the\\ likely\\ culprit\\.\ \(0\)\
\-\ radiographic\\ and\\ pathologic\\ characteristics\\ of\\ osteonecrosis\\ due\\ to\\ corticosteroids\\ are\\ not\\ unique\\,\\ being\\ also\\ evident\\ in\\ cases\\ of\\ bony\\ necrosis\\ from\\ other\\ causes\\.\\ \\ osteoporosis\\,\\ patchy\\ osteonecrosis\\,\\ subchondral\\ radiolucent\\ lines\\ \\(crescent\\ sign\\)\\,\\ osseous\\ collapse\\,\\ and\\ fragmentation\\ are\\ recognized\\.\\ \\ preservation\\ of\\ joint\\ space\\ is\\ also\\ typical\\ during\\ the\\ early\\ stages\\ of\\ the\\ process\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteonecrosis\\:\\ 0\\.44180113584817404\ \(0\)\
\-\ steroid\\:\\ 0\\.2598463797757315\ \(0\)\
\-\ fragmentation\\:\\ 0\\.1679545669102189\ \(0\)\
\-\ crescent\\:\\ 0\\.16642950725374794\ \(0\)\
\-\ avn\\:\\ 0\\.16115657534095196\ \(0\)\
\-\ recognized\\:\\ 0\\.1486177113568568\ \(0\)\
\-\ radiolucent\\:\\ 0\\.1472670452827247\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.1436244303191589\ \(0\)\
\-\ lines\\:\\ 0\\.13442129097019417\ \(0\)\
\-\ him\\:\\ 0\\.13404319933364725\ \(0\)\
\-\ induced\\:\\ 0\\.13367106214419078\ \(0\)\
\-\ patchy\\:\\ 0\\.13121832074688658\ \(0\)\
\-\ crohn\\:\\ 0\\.13121832074688658\ \(0\)\
\-\ humeral\\:\\ 0\\.12992318988786575\ \(0\)\
\-\ subchondral\\:\\ 0\\.1289963956838184\ \(0\)\
\-\ collapse\\:\\ 0\\.12641599204649284\ \(0\)\
\-\ diseases\\:\\ 0\\.12384495618853808\ \(0\)\
\-\ steroids\\:\\ 0\\.11842630815220621\ \(0\)\
\-\ disease\\:\\ 0\\.11316463282237485\ \(0\)\
\-\ osseous\\:\\ 0\\.10758785392185358\ \(0\)\
\-\ term\\:\\ 0\\.10570584693890442\ \(0\)\
\-\ of\\:\\ 0\\.10551544538063161\ \(0\)\
\-\ use\\:\\ 0\\.10313714239736368\ \(0\)\
\-\ practices\\:\\ 0\\.10299297196628603\ \(0\)\
\-\ causes\\:\\ 0\\.10185418474535377\ \(0\)\
\-\ risk\\:\\ 0\\.09631381010378794\ \(0\)\
\-\ culprit\\:\\ 0\\.09480336068889673\ \(0\)\
\-\ the\\:\\ 0\\.09413797655279244\ \(0\)\
\-\ sign\\:\\ 0\\.09332044816526072\ \(0\)\
\-\ mnemonic\\:\\ 0\\.0900127451961409\ \(0\)\
\-\ long\\:\\ 0\\.08938322374807957\ \(0\)\
\-\ caisson\\:\\ 0\\.08876789894786527\ \(0\)\
\-\ dz\\:\\ 0\\.08397728345510945\ \(0\)\
\-\ placing\\:\\ 0\\.08397728345510945\ \(0\)\
\-\ alcoholism\\:\\ 0\\.08321475362687397\ \(0\)\
\-\ gaucher\\:\\ 0\\.0824984669558177\ \(0\)\
\-\ erythematosus\\:\\ 0\\.08000182643696874\ \(0\)\
\-\ trauma\\:\\ 0\\.07828401756819574\ \(0\)\
\-\ are\\:\\ 0\\.0767230805213389\ \(0\)\
\-\ amyloid\\:\\ 0\\.07618822279339152\ \(0\)\
\-\ unique\\:\\ 0\\.07578767217772016\ \(0\)\
\-\ atherosclerosis\\:\\ 0\\.07466157176893692\ \(0\)\
\-\ tx\\:\\ 0\\.07396636469593727\ \(0\)\
\-\ preservation\\:\\ 0\\.07363352264136235\ \(0\)\
\-\ furthermore\\:\\ 0\\.0733098007042427\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.072994712389412\ \(0\)\
\-\ heads\\:\\ 0\\.07268780911929848\ \(0\)\
\-\ stages\\:\\ 0\\.07209693042021129\ \(0\)\
\-\ lupus\\:\\ 0\\.07023452685672886\ \(0\)\
\-\ other\\:\\ 0\\.07000141056391078\ \(0\)\
\-\ and\\:\\ 0\\.06963454303300937\ \(0\)\
\-\ collagen\\:\\ 0\\.06841321937494597\ \(0\)\
\-\ making\\:\\ 0\\.06740276535349239\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.06683553107209539\ \(0\)\
\-\ sickle\\:\\ 0\\.06665234737826703\ \(0\)\
\-\ particular\\:\\ 0\\.065776753418548\ \(0\)\
\-\ multifocal\\:\\ 0\\.06544391136397305\ \(0\)\
\-\ becomes\\:\\ 0\\.0644981978419092\ \(0\)\
\-\ 95\\:\\ 0\\.063907319142822\ \(0\)\
\-\ also\\:\\ 0\\.06340388868608687\ \(0\)\
\-\ significantly\\:\\ 0\\.06334458842983351\ \(0\)\
\-\ 43\\:\\ 0\\.06307296470691418\ \(0\)\
\-\ characteristics\\:\\ 0\\.061801296400407275\ \(0\)\
\-\ for\\:\\ 0\\.06128317265627535\ \(0\)\
\-\ higher\\:\\ 0\\.061213358612742026\ \(0\)\
\-\ place\\:\\ 0\\.06076320467845271\ \(0\)\
\-\ leading\\:\\ 0\\.059911296215960905\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.05940844962294158\ \(0\)\
\-\ evident\\:\\ 0\\.05792963312364982\ \(0\)\
\-\ idiopathic\\:\\ 0\\.057010680907651455\ \(0\)\
\-\ pathologic\\:\\ 0\\.05522387012651108\ \(0\)\
\-\ pregnancy\\:\\ 0\\.055154977152444225\ \(0\)\
\-\ arthritis\\:\\ 0\\.054816412108376567\ \(0\)\
\-\ good\\:\\ 0\\.054816412108376567\ \(0\)\
\-\ typical\\:\\ 0\\.052086860942258825\ \(0\)\
\-\ bony\\:\\ 0\\.05192897291463324\ \(0\)\
\-\ necrosis\\:\\ 0\\.0515179710717641\ \(0\)\
\-\ history\\:\\ 0\\.0514996426855151\ \(0\)\
\-\ at\\:\\ 0\\.05091392556690578\ \(0\)\
\-\ process\\:\\ 0\\.050548976534134676\ \(0\)\
\-\ radiographic\\:\\ 0\\.050003566860094724\ \(0\)\
\-\ involvement\\:\\ 0\\.04878095036734511\ \(0\)\
\-\ early\\:\\ 0\\.048582372389154305\ \(0\)\
\-\ being\\:\\ 0\\.04696536587505494\ \(0\)\
\-\ this\\:\\ 0\\.04631812374224511\ \(0\)\
\-\ cases\\:\\ 0\\.04533199631979387\ \(0\)\
\-\ cancer\\:\\ 0\\.044891630631645425\ \(0\)\
\-\ space\\:\\ 0\\.04486284837240151\ \(0\)\
\-\ radiation\\:\\ 0\\.044663312192062925\ \(0\)\
\-\ joint\\:\\ 0\\.04441161982417511\ \(0\)\
\-\ several\\:\\ 0\\.044219499955779805\ \(0\)\
\-\ past\\:\\ 0\\.04387078803773536\ \(0\)\
\-\ any\\:\\ 0\\.04355778664538236\ \(0\)\
\-\ during\\:\\ 0\\.04268954954242449\ \(0\)\
\-\ yo\\:\\ 0\\.042106256790035566\ \(0\)\
\-\ years\\:\\ 0\\.04131388542292102\ \(0\)\
\-\ infection\\:\\ 0\\.0407121078917983\ \(0\)\
\-\ likely\\:\\ 0\\.040275196842509776\ \(0\)\
\-\ head\\:\\ 0\\.04019746556492654\ \(0\)\
\-\ he\\:\\ 0\\.03991044469172486\ \(0\)\
\-\ significant\\:\\ 0\\.03891394461247325\ \(0\)\
\-\ due\\:\\ 0\\.0387414581684265\ \(0\)\
\-\ cell\\:\\ 0\\.03855458694392474\ \(0\)\
\-\ both\\:\\ 0\\.03758426534281376\ \(0\)\
\-\ is\\:\\ 0\\.03691463356916855\ \(0\)\
\-\ bilateral\\:\\ 0\\.036222008546785825\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03493848759433254\ \(0\)\
\-\ case\\:\\ 0\\.03385986927856319\ \(0\)\
\-\ had\\:\\ 0\\.0335800098758982\ \(0\)\
\-\ has\\:\\ 0\\.03078530345271708\ \(0\)\
\-\ male\\:\\ 0\\.030008046664027677\ \(0\)\
\-\ that\\:\\ 0\\.029248072283315232\ \(0\)\
\-\ from\\:\\ 0\\.02676750724576046\ \(0\)\
\-\ not\\:\\ 0\\.02660700691925129\ \(0\)\
\-\ with\\:\\ 0\\.0263946227085259\ \(0\)\
\-\ or\\:\\ 0\\.02344645811918969\ \(0\)\
\-\ patient\\:\\ 0\\.021921086871413184\ \(0\)\
\-\ no\\:\\ 0\\.021916963642763174\ \(0\)\
\-\ to\\:\\ 0\\.0168492914596368\ \(0\)\
\-\ in\\:\\ 0\\.01676635928196855\ \(0\)\
